Send to

Choose Destination
Clin Toxicol (Phila). 2018 Dec 26:1-6. doi: 10.1080/15563650.2018.1510128. [Epub ahead of print]

Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk.

Author information

a Department of Emergency Medicine , Morristown Medical Center , Morristown , NJ , USA.
b Department of Emergency Medicine , Rutgers New Jersey Medical School , Newark , NJ , USA.
c Department of Emergency Medicine, New Jersey Poison Information and Education System , Rutgers New Jersey Medical School , Newark , NJ , USA.
d UT Southwestern Medical School , Dallas , TX , USA.
e American College of Medical Toxicology , Phoenix , AZ , USA.
f School of Medicine , University of Colorado , Aurora , CO , USA.



Loperamide is a readily accessible nonprescription medication that is increasingly being used surreptitiously as an opioid substitute to alleviate the symptoms of acute opioid withdrawal. The objective of this study was to determine the clinical characteristics of patients with loperamide misuse and toxicity.


The ToxIC registry, a nationwide, prospectively collected cohort of patients evaluated by medical toxicologists was searched from November 2011-December 2016 for patients with loperamide exposure. Each record was reviewed to determine the circumstances, dose, clinical presentations, treatment, and outcomes associated with loperamide use.


Twenty-six cases were identified, and both the absolute number and relative proportion of overall cases in the ToxIC registry increased annually. The median age was 27 and 54% were male. Of cases with known intent (n = 18), 12(67%) were misuse/abuse, 3(17%) were self-harm/suicide, and 3(17%) were pediatric exploratory ingestions. Circumstances for misuse included taking higher doses than labeled (n =7), avoiding withdrawal (n = 6), and gaining a pleasurable sensation (n =4). The dose was reported in nine cases and ranged from 4 mg to 400 mg. In patients seeking to avoid withdrawal doses were 160-400 mg/day; the most common reported dose was 200 mg. Reported ECG abnormalities included 10 cases of prolonged QTc (>500 ms), which consisted of misuse/abuse (n =6) and self-harm (n =1) exposures; six prolonged QRS (>120 ms); two first degree AV block; seven ventricular dysrhythmias, five of which were single-agent exposures. All but one ECG demonstrated prolonged QTc with a range of 566-749 ms. All patients with dysrhythmias in which dose were reported ingested ≥200 mg.


The majority of patients had loperamide toxicity due to misuse/abuse, in-line with national trends. In patients avoiding withdrawal, doses >100 mg were observed. When taken in large doses (>200 mg), loperamide may cause significant cardiovascular effects, including QTc-prolongation and ventricular dysrhythmias.


Cardiac arrhythmia; loperamide; substance abuse

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center